click below
click below
Normal Size Small Size show me how
Drug Discovery
| Term | Definition |
|---|---|
| Phase 1 clinical trial | Only clinical trail on healthy subjects |
| Phase 2 clinical trail | Determine drug efficacy in up to several hundreds patients and to asses potential side effects |
| Phase 3 clinical trail | Conducted in several hundred to several thousand patients to determine drug safety, efficacy, and risk/benefit ratio |
| Phase 4 clinical trail | Conducted after a drug is marketed |
| United States Pharmacopeia (USP) | Sets drug standards for identity, strength and quality/ purity |
| Food and drug Administration (FDA) | Enforces drug standards and ensure that drugs are safe |
| Investigational New Drug Application (IND) | New drug can be tested in clinical trials |
| New Drug Application (NDA) | New drug is marketed for human use |
| New Animal Drug Application (NADA) | New drug is marketed for animal use |
| Abbreviated New Drug Application (ANDA) | Generic drug is marked for human use |
| Supplemental New Drug Application (sNDA) | New formulation for an already approved drug can be marketed |
| Biological License Application (BLA) | New biological drug (such as protein or vaccine) is marketed for human use |
| Pharmacology | Study of drug action |
| Toxicology | Study of drug adverse effects |
| Formulation | Components and amount of active and inactive ingredients in a drug product or preparation |
| Pre clinical studies | Conducted on animals, when a drug is being developed for human use |
| Class 1 recall | Use of or exposure to the product will cause serious adverse health effect or death |
| Class 2 recall | May cause temporary or reversible adverse health or probability of serious adverse health effect is remote |
| Class 3 recall | Not likely to case adverse health effect |